Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
1933 IndustriesTGIFF -22.00% EV-to-FCF is 9.17 as of Aug. 25, 2026. The stock has 2 warning signs investors should review. Among 559 Drug Manufacturers companies, 1933 Industries ranks better than 79.79% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, 1933 Industries's Enterprise Value is $13.86 Mil.
1933 Industries's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was $1.51 Mil. Therefore, 1933 Industries's EV-to-FCF for today is 9.17.
The historical rank and industry rank for 1933 Industries's EV-to-FCF or its related term are showing as below:
TGIFF'
s EV-to-FCF Range Over the Past 10 Years
Min: -31.17 Med: -5.3 Max: 51.74
Current: 9.17
During the past 13 years, the highest EV-to-FCF of 1933 Industries was 51.74. The lowest was -31.17. And the median was -5.30.
TGIFF's EV-to-FCF is ranked better than 79.79% of 559
companies
in the Drug Manufacturers industry
Industry Median: 21.02
vs TGIFF: 9.17
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
1933 Industries's PE Ratio (TTM) for today is calculated as:
1933 Industries's share price for today is $0.0039.
1933 Industries's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
1933 Industries EV-to-FCF Related Terms
1933 Industries EV-to-FCF Historical Data
* Premium members only.
The historical data trend for 1933 Industries's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
1933 Industries EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where 1933 Industries's EV-to-FCF falls into.
1933 Industries's current Enterprise Value is $13.86 Mil.
1933 Industries's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1933 Industries (TGIFF) has a EV-to-FCF of 9.17 as of Aug. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on 1933 Industries and its competitors. According to the industry distribution chart, 1933 Industries ranks #113 out of 559 companies in the Drug Manufacturers industry, placing it in the top 20.2%.
Is 1933 Industries' EV-to-FCF too high?
1933 Industries' current EV-to-FCF is 9.17. The Drug Manufacturers industry median EV-to-FCF is 21.02. 1933 Industries' value of 9.17 is 56.4% below this industry median. Based on the distribution chart, 1933 Industries ranks #113 out of 559 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does 1933 Industries' EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, 1933 Industries ranks #113 out of 559 companies for EV-to-FCF. This places 1933 Industries in the top 20% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 21.02. 1933 Industries' value of 9.17 is 56.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.02, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 1933 Industries's current EV-to-FCF of 9.17 is 56.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on 1933 Industries and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1933 Industries's current EV-to-FCF is 9.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1933 Industries stock overvalued right now?
Based on GuruFocus' analysis, 1933 Industries (TGIFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 61% below its estimated fair value. The current EV-to-FCF is 9.17 and 56.4% below the Drug Manufacturers industry median of 21.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For 1933 Industries (TGIFF), the current EV-to-FCF is 9.17 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGIFF has been successfully added to your 
